Drugs / MK0429
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00302471 | Mar 2006 → Oct 2007 | prostate cancer | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00533650 | Dec 2000 → Oct 2002 | postmenopausal osteoporosis | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MK0429 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00302471 ↗ |